IBDEI2KV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41141,1,3,0)
 ;;=3^Asthma,Moderate Persistent,Uncomplicated
 ;;^UTILITY(U,$J,358.3,41141,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,41141,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,41142,0)
 ;;=J44.9^^152^2026^24
 ;;^UTILITY(U,$J,358.3,41142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41142,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,41142,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,41142,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,41143,0)
 ;;=J44.1^^152^2026^22
 ;;^UTILITY(U,$J,358.3,41143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41143,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41143,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,41143,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,41144,0)
 ;;=J47.0^^152^2026^15
 ;;^UTILITY(U,$J,358.3,41144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41144,1,3,0)
 ;;=3^Bronchiectasis w/ Acute Lower Resp Infection
 ;;^UTILITY(U,$J,358.3,41144,1,4,0)
 ;;=4^J47.0
 ;;^UTILITY(U,$J,358.3,41144,2)
 ;;=^5008258
 ;;^UTILITY(U,$J,358.3,41145,0)
 ;;=J47.1^^152^2026^14
 ;;^UTILITY(U,$J,358.3,41145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41145,1,3,0)
 ;;=3^Bronchiectasis w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41145,1,4,0)
 ;;=4^J47.1
 ;;^UTILITY(U,$J,358.3,41145,2)
 ;;=^5008259
 ;;^UTILITY(U,$J,358.3,41146,0)
 ;;=J47.9^^152^2026^16
 ;;^UTILITY(U,$J,358.3,41146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41146,1,3,0)
 ;;=3^Bronchiectasis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,41146,1,4,0)
 ;;=4^J47.9
 ;;^UTILITY(U,$J,358.3,41146,2)
 ;;=^5008260
 ;;^UTILITY(U,$J,358.3,41147,0)
 ;;=J45.41^^152^2026^8
 ;;^UTILITY(U,$J,358.3,41147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41147,1,3,0)
 ;;=3^Asthma,Moderate Persistent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41147,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,41147,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,41148,0)
 ;;=J45.42^^152^2026^9
 ;;^UTILITY(U,$J,358.3,41148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41148,1,3,0)
 ;;=3^Asthma,Moderate Persistent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,41148,1,4,0)
 ;;=4^J45.42
 ;;^UTILITY(U,$J,358.3,41148,2)
 ;;=^5008250
 ;;^UTILITY(U,$J,358.3,41149,0)
 ;;=J45.51^^152^2026^12
 ;;^UTILITY(U,$J,358.3,41149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41149,1,3,0)
 ;;=3^Asthma,Severe Persistent w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41149,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,41149,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,41150,0)
 ;;=J45.52^^152^2026^13
 ;;^UTILITY(U,$J,358.3,41150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41150,1,3,0)
 ;;=3^Asthma,Severe Persistent w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,41150,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,41150,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,41151,0)
 ;;=J45.901^^152^2026^1
 ;;^UTILITY(U,$J,358.3,41151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41151,1,3,0)
 ;;=3^Asthma w/ Acute Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,41151,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,41151,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,41152,0)
 ;;=J45.902^^152^2026^2
 ;;^UTILITY(U,$J,358.3,41152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41152,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,41152,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,41152,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,41153,0)
 ;;=J45.990^^152^2026^31
